Clinical Use Of Bivalirudin Nonhit Patients A Treatment of Deep Vein Thrombosis

Bivalirudin is not approved for the treatment of venous thromboembolism. However, it has been evaluated in animal models of venous and arterial thrombosis

TABLE 3 Adverse Events Occurring in >5% of Patients Receiving Bivalirudin or Heparin in Randomized Clinical Trials

Event Bivalirudin (n = 2161) Heparin (n = 2151)

TABLE 3 Adverse Events Occurring in >5% of Patients Receiving Bivalirudin or Heparin in Randomized Clinical Trials

Event Bivalirudin (n = 2161) Heparin (n = 2151)

Cardiovascular

0 0

Post a comment